Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated:  8/28/2015
Medical Center of Central Georgia - Pediatric Intensive Care Unit
mi
from
Macon, GA
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry
Pediatric Critical Illness Hyperglycemia and Glycemic Control Registry: A Project to Assist in the Improved Understanding of Hyperglycemia and Glycemic Control in Pediatric Critical Illness.
Status: Enrolling
Updated: 8/28/2015
Medical Center of Central Georgia - Pediatric Intensive Care Unit
mi
from
Macon, GA
Click here to add this to my saved trials
Pediatric Intensive Care Units (ICUs) at Emory-Children's Center Glycemic Control: The PedETrol Trial
Pediatric ICUs at Emory-Children's Center Glycemic Control: The PedETrol Trial
Status: Enrolling
Updated:  8/28/2015
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Pediatric Intensive Care Units (ICUs) at Emory-Children's Center Glycemic Control: The PedETrol Trial
Pediatric ICUs at Emory-Children's Center Glycemic Control: The PedETrol Trial
Status: Enrolling
Updated: 8/28/2015
Children's Healthcare of Atlanta - Egleston
mi
from
Atlanta, GA
Click here to add this to my saved trials
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Status: Enrolling
Updated:  8/31/2015
Stanford University
mi
from
Stanford, CA
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Status: Enrolling
Updated: 8/31/2015
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Status: Enrolling
Updated:  8/31/2015
Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Status: Enrolling
Updated: 8/31/2015
Barbara Davis Center for Childhood Diabetes
mi
from
Aurora, CO
Click here to add this to my saved trials
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Status: Enrolling
Updated:  8/31/2015
St. Joseph's Health Care
mi
from
London,
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in Children
Status: Enrolling
Updated: 8/31/2015
St. Joseph's Health Care
mi
from
London,
Click here to add this to my saved trials
Interprofessional Training to Improve Diabetes Care: The ReSPECT Trial
Interprofessional Training for Improving Diabetes Care
Status: Enrolling
Updated:  9/2/2015
Louis Stokes VA Medical Center
mi
from
Cleveland, OH
Interprofessional Training to Improve Diabetes Care: The ReSPECT Trial
Interprofessional Training for Improving Diabetes Care
Status: Enrolling
Updated: 9/2/2015
Louis Stokes VA Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns
A Description of Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns Including Initiation, Switching, and Discontinuation
Status: Enrolling
Updated:  9/2/2015
205.440.1003 Boehringer Ingelheim Investigational Site
mi
from
Boston, MA
Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns
A Description of Oral and Non-insulin Injected Hypoglycemic Therapy Utilization Patterns Including Initiation, Switching, and Discontinuation
Status: Enrolling
Updated: 9/2/2015
205.440.1003 Boehringer Ingelheim Investigational Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Mobile, AL
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Little Rock, AR
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Concord, CA
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Concord, CA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Fresno, CA
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Tampa, FL
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
West Palm Beach, FL
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Honolulu, HI
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Idaho Falls, ID
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Crystal Lake, IL
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Crystal Lake, IL
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Des Moines, IA
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Des Moines, IA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Topeka, KA
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Topeka, KA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Louisville, KY
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Bangor, ME
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Bangor, ME
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Baltimore, MD
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Columbia, MO
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Columbia, MO
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Springfield, MO
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Springfield, MO
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Omaha, NE
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Nashua, NH
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Nashua, NH
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Durham, NC
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Greenville, NC
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Greenville, NC
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Chattanooga, TN
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Nashville, TN
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Beaumont, TX
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Beaumont, TX
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Dallas, TX
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Norfolk, VA
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Federal Way, WA
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Federal Way, WA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Olympia, WA
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Olympia, WA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Renton, WA
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Renton, WA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Spokane, WA
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Tacoma, WA
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated:  9/3/2015
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Bayamon,
Study of Human Regular U-500 Insulin in Adult Participants With Type 2 Diabetes
Two Treatment Approaches for Human Regular U-500 Insulin (Thrice-Daily Versus Twice-Daily) in Subjects With Type 2 Diabetes Mellitus Not Achieving Adequate Glycemic Control on High-Dose U-100 Insulin Therapy With or Without Oral Agents: A Randomized, Open-Label, Parallel Clinical Trial
Status: Enrolling
Updated: 9/3/2015
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
mi
from
Bayamon,
Click here to add this to my saved trials
A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
A Two-Cohort, Single- and Repeat Dose Study to Examine the Pharmacokinetics, Tolerability, and Safety of Ready to Use Exenatide Once Weekly in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  9/3/2015
Clinical Research Facility
mi
from
Lincoln, NE
A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
A Two-Cohort, Single- and Repeat Dose Study to Examine the Pharmacokinetics, Tolerability, and Safety of Ready to Use Exenatide Once Weekly in Healthy Subjects and in Subjects With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 9/3/2015
Clinical Research Facility
mi
from
Lincoln, NE
Click here to add this to my saved trials
Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1
Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1
Status: Enrolling
Updated:  9/9/2015
St. Luke's Roosevelt Hospital-New York Obesity Nutrition Research Center
mi
from
New York, NY
Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1
Mechanisms of Diabetes Control After Weight Loss Surgery, Sub-study #1
Status: Enrolling
Updated: 9/9/2015
St. Luke's Roosevelt Hospital-New York Obesity Nutrition Research Center
mi
from
New York, NY
Click here to add this to my saved trials
Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes
Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Volunteers With Type 1 Diabetes
Status: Enrolling
Updated:  9/11/2015
Massachusetts General Hospital
mi
from
Boston, MA
Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Type 1 Diabetes
Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin and Glucagon Delivery in Volunteers With Type 1 Diabetes
Status: Enrolling
Updated: 9/11/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
CONtrolling Disease Using Inexpensive IT - Hypertension in Diabetes
CONtrolling Disease Using Inexpensive IT - Hypertension in Diabetes
Status: Enrolling
Updated:  9/15/2015
Reliant Medical Group
mi
from
Worcester, MA
CONtrolling Disease Using Inexpensive IT - Hypertension in Diabetes
CONtrolling Disease Using Inexpensive IT - Hypertension in Diabetes
Status: Enrolling
Updated: 9/15/2015
Reliant Medical Group
mi
from
Worcester, MA
Click here to add this to my saved trials
Mobile Insulin Titration Intervention
The Mobile Insulin Titration Intervention (MITI) Study: Innovative Chronic Disease Management of Diabetes
Status: Enrolling
Updated:  9/15/2015
Adult Primary Care Clinic, Bellevue Hospital Center
mi
from
New York, NY
Mobile Insulin Titration Intervention
The Mobile Insulin Titration Intervention (MITI) Study: Innovative Chronic Disease Management of Diabetes
Status: Enrolling
Updated: 9/15/2015
Adult Primary Care Clinic, Bellevue Hospital Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
An Exploratory Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Design Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZD1722 in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
Status: Enrolling
Updated:  9/18/2015
Creekside Endocrine Associates PC
mi
from
Denver, CO
A Study in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
An Exploratory Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Design Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of AZD1722 in CKD Patients With Type 2 Diabetes Mellitus and Albuminuria
Status: Enrolling
Updated: 9/18/2015
Creekside Endocrine Associates PC
mi
from
Denver, CO
Click here to add this to my saved trials
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
Status: Enrolling
Updated:  9/20/2015
Northwestern University Medical Center
mi
from
Chicago, IL
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal Insufficiency
Status: Enrolling
Updated: 9/20/2015
Northwestern University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials